RARE Insider Transactions
| Transaction Date (SEC Report) |
Reporting Name | Relationship | Shrs. Owned | Type | Acq./Disp. | Shrs. Transacted | Price() | Amount() |
|---|---|---|---|---|---|---|---|---|
| 2024-04-16 | Huizenga Theodore Alan | officer: SVP, Chief Accounting Officer | 41,366 | F-InKind | D | 14 | 42.31 | 592.30 |
| 2024-03-11 | Kassberg Thomas Richard | officer: CBO & EVP | 252,823 | S-Sale | D | 11,509 | 49.93 | 574,644.00 |
| 2024-03-07 | Fust Matthew K | director | 24,505 | S-Sale | D | 2,550 | 50.89 | 129,770.00 |
| 2024-03-07 | Fust Matthew K | director | 22,360 | S-Sale | D | 2,145 | 50.85 | 109,073.00 |
| 2024-03-07 | Fust Matthew K | director | 14,860 | S-Sale | D | 7,500 | 50.88 | 381,600.00 |
| 2024-03-01 | Horn Howard | officer: Chief Financial Officer | 99,766 | A-Award | A | 19,400 | 0.00 | 0.00 |
| 2024-03-01 | Horn Howard | officer: Chief Financial Officer | 34,200 | A-Award | A | 34,200 | 53.69 | 1,836,198.00 |
| 2024-03-01 | Parschauer Karah Herdman | officer: EVP and Chief Legal Officer | 70,739 | A-Award | A | 957 | 0.00 | 0.00 |
| 2024-03-01 | Parschauer Karah Herdman | officer: EVP and Chief Legal Officer | 69,782 | A-Award | A | 17,800 | 0.00 | 0.00 |
| 2024-03-01 | Parschauer Karah Herdman | officer: EVP and Chief Legal Officer | 67,340 | S-Sale | D | 3,756 | 53.76 | 201,923.00 |
| 2024-03-01 | Parschauer Karah Herdman | officer: EVP and Chief Legal Officer | 31,400 | A-Award | A | 31,400 | 53.69 | 1,685,866.00 |
| 2024-03-01 | Kassberg Thomas Richard | officer: CBO & EVP | 265,617 | A-Award | A | 957 | 0.00 | 0.00 |
| 2024-03-01 | Kassberg Thomas Richard | officer: CBO & EVP | 265,343 | F-InKind | D | 274 | 53.69 | 14,711.00 |
| 2024-03-01 | Kassberg Thomas Richard | officer: CBO & EVP | 264,660 | A-Award | A | 17,800 | 0.00 | 0.00 |
| 2024-03-01 | Kassberg Thomas Richard | officer: CBO & EVP | 264,332 | S-Sale | D | 1,011 | 53.76 | 54,351.00 |
| 2024-03-01 | Kassberg Thomas Richard | officer: CBO & EVP | 31,400 | A-Award | A | 31,400 | 53.69 | 1,685,866.00 |
| 2024-03-01 | Huang Dennis Karl | officer: See Remarks | 83,472 | A-Award | A | 957 | 0.00 | 0.00 |
| 2024-03-01 | Huang Dennis Karl | officer: See Remarks | 83,002 | F-InKind | D | 470 | 53.69 | 25,234.00 |
| 2024-03-01 | Huang Dennis Karl | officer: See Remarks | 82,515 | A-Award | A | 17,800 | 0.00 | 0.00 |
| 2024-03-01 | Huang Dennis Karl | officer: See Remarks | 31,400 | A-Award | A | 31,400 | 53.69 | 1,685,866.00 |
| 2024-03-01 | Pinion John Richard | officer: See Remarks | 93,501 | A-Award | A | 957 | 0.00 | 0.00 |
| 2024-03-01 | Pinion John Richard | officer: See Remarks | 93,441 | F-InKind | D | 60 | 53.69 | 3,221.00 |
| 2024-03-01 | Pinion John Richard | officer: See Remarks | 92,544 | A-Award | A | 17,800 | 0.00 | 0.00 |
| 2024-03-01 | Pinion John Richard | officer: See Remarks | 89,268 | S-Sale | D | 4,173 | 53.76 | 224,340.00 |
| 2024-03-01 | Pinion John Richard | officer: See Remarks | 31,400 | A-Award | A | 31,400 | 53.69 | 1,685,866.00 |
| 2024-03-01 | Huizenga Theodore Alan | officer: SVP, Chief Accounting Officer | 41,842 | A-Award | A | 13,950 | 0.00 | 0.00 |
| 2024-03-01 | Huizenga Theodore Alan | officer: SVP, Chief Accounting Officer | 41,721 | F-InKind | D | 121 | 53.69 | 6,496.00 |
| 2024-03-01 | Huizenga Theodore Alan | officer: SVP, Chief Accounting Officer | 41,380 | S-Sale | D | 341 | 53.76 | 18,332.00 |
| 2024-03-01 | Huizenga Theodore Alan | officer: SVP, Chief Accounting Officer | 8,200 | A-Award | A | 8,200 | 53.69 | 440,258.00 |
| 2024-03-01 | Huizenga Theodore Alan | officer: SVP, Chief Accounting Officer | 2,351 | A-Award | A | 2,351 | 67.37 | 158,387.00 |
| 2024-03-01 | Crombez Eric | officer: EVP and Chief Medical Officer | 49,912 | A-Award | A | 19,400 | 0.00 | 0.00 |
| 2024-03-01 | Crombez Eric | officer: EVP and Chief Medical Officer | 48,927 | S-Sale | D | 1,238 | 53.76 | 66,555.00 |
| 2024-03-01 | Crombez Eric | officer: EVP and Chief Medical Officer | 34,200 | A-Award | A | 34,200 | 53.69 | 1,836,198.00 |
| 2024-03-01 | Crombez Eric | officer: EVP and Chief Medical Officer | 2,351 | A-Award | A | 2,351 | 67.37 | 158,387.00 |
| 2024-03-01 | Harris Erik | officer: EVP & Chief Commercial Officer | 71,638 | A-Award | A | 957 | 0.00 | 0.00 |
| 2024-03-01 | Harris Erik | officer: EVP & Chief Commercial Officer | 70,681 | A-Award | A | 19,400 | 0.00 | 0.00 |
| 2024-03-01 | Harris Erik | officer: EVP & Chief Commercial Officer | 67,163 | S-Sale | D | 4,768 | 53.76 | 256,328.00 |
| 2024-03-01 | Harris Erik | officer: EVP & Chief Commercial Officer | 34,200 | A-Award | A | 34,200 | 53.69 | 1,836,198.00 |
| 2024-03-01 | KAKKIS EMIL D | director, officer: President & CEO | 578,198 | A-Award | A | 38,428 | 0.00 | 0.00 |
| 2024-03-01 | KAKKIS EMIL D | director, officer: President & CEO | 563,913 | A-Award | A | 3,132 | 0.00 | 0.00 |
| 2024-03-01 | KAKKIS EMIL D | director, officer: President & CEO | 560,781 | F-InKind | D | 17,417 | 53.69 | 935,119.00 |
| 2024-03-01 | KAKKIS EMIL D | director, officer: President & CEO | 70,094 | A-Award | A | 70,094 | 53.69 | 3,763,347.00 |
| 2024-02-07 | KAKKIS EMIL D | director, officer: President & CEO | 539,770 | S-Sale | D | 30,000 | 45.00 | 1,350,000.00 |
| 2023-12-29 | KAKKIS EMIL D | director, officer: President & CEO | 569,770 | S-Sale | D | 30,000 | 47.87 | 1,436,100.00 |
| 2024-01-02 | Huizenga Theodore Alan | officer: SVP, Chief Accounting Officer | 27,892 | M-Exempt | A | 3,000 | 21.00 | 63,000.00 |
| 2023-12-20 | Huizenga Theodore Alan | officer: SVP, Chief Accounting Officer | 24,614 | A-Award | A | 1,000 | 0.00 | 0.00 |
| 2024-01-02 | Huizenga Theodore Alan | officer: SVP, Chief Accounting Officer | 0 | M-Exempt | D | 3,000 | 21.00 | 63,000.00 |
| 2023-10-23 | Kassberg Thomas Richard | officer: CBO & EVP | 286,738 | M-Exempt | A | 39,878 | 6.86 | 273,563.00 |
| 2023-10-23 | Kassberg Thomas Richard | officer: CBO & EVP | 246,860 | S-Sale | D | 39,878 | 32.78 | 1,307,201.00 |
| 2023-10-23 | Kassberg Thomas Richard | officer: CBO & EVP | 0 | M-Exempt | D | 39,878 | 6.86 | 273,563.00 |
| 2023-10-19 | KAKKIS EMIL D | director, officer: President & CEO | 647,029 | M-Exempt | A | 47,853 | 6.86 | 328,272.00 |
| 2023-10-19 | KAKKIS EMIL D | director, officer: President & CEO | 599,743 | S-Sale | D | 47,853 | 33.52 | 1,604,033.00 |
| 2023-10-19 | KAKKIS EMIL D | director, officer: President & CEO | 0 | M-Exempt | D | 47,853 | 6.86 | 328,272.00 |
| 2023-10-09 | Horn Howard | officer: Chief Financial Officer | 140,469 | A-Award | A | 140,469 | 35.68 | 5,011,934.00 |
| 2023-10-09 | Horn Howard | officer: Chief Financial Officer | 80,336 | A-Award | A | 80,366 | 0.00 | 0.00 |
| 2023-10-09 | Horn Howard | officer | 0 | 0 | 0.00 | 0.00 | ||
| 2023-09-27 | Huizenga Theodore Alan | officer: SVP, Chief Accounting Officer | 2,351 | A-Award | A | 2,351 | 67.37 | 158,387.00 |
| 2023-09-27 | Crombez Eric | officer: EVP and Chief Medical Officer | 2,351 | A-Award | A | 2,351 | 67.37 | 158,387.00 |
| 2023-09-07 | Huizenga Theodore Alan | officer: SVP, Chief Accounting Officer | 25,777 | M-Exempt | A | 2,000 | 21.00 | 42,000.00 |
| 2023-09-07 | Huizenga Theodore Alan | officer: SVP, Chief Accounting Officer | 23,777 | S-Sale | D | 2,000 | 41.00 | 82,000.00 |
| 2023-09-07 | Huizenga Theodore Alan | officer: SVP, Chief Accounting Officer | 23,614 | S-Sale | D | 163 | 38.34 | 6,249.00 |
| 2023-09-07 | Huizenga Theodore Alan | officer: SVP, Chief Accounting Officer | 3,000 | M-Exempt | D | 2,000 | 21.00 | 42,000.00 |
| 2023-09-05 | Harris Erik | officer: EVP & Chief Commercial Officer | 51,281 | S-Sale | D | 6,000 | 37.96 | 227,760.00 |
| 2023-09-01 | Huizenga Theodore Alan | officer: SVP, Chief Accounting Officer | 23,864 | S-Sale | D | 883 | 37.04 | 32,706.00 |
| 2023-09-01 | Huizenga Theodore Alan | officer: SVP, Chief Accounting Officer | 23,777 | S-Sale | D | 87 | 38.23 | 3,326.00 |
| 2023-06-30 | Sanders Corazon (Corsee) D. | director | 8,985 | S-Sale | D | 585 | 46.76 | 27,355.00 |
| 2023-06-19 | Harris Erik | officer: EVP & Chief Commercial Officer | 57,281 | S-Sale | D | 305 | 48.20 | 14,701.00 |
| 2023-06-07 | Ray Amrit | director | 12,280 | A-Award | A | 3,860 | 0.00 | 0.00 |
| 2023-06-07 | Ray Amrit | director | 7,110 | A-Award | A | 7,110 | 51.82 | 368,440.00 |
| 2023-06-07 | Fust Matthew K | director | 30,355 | A-Award | A | 3,860 | 0.00 | 0.00 |
| 2023-06-07 | Fust Matthew K | director | 27,055 | D-Return | D | 3,300 | 51.82 | 171,006.00 |
| 2023-06-07 | Fust Matthew K | director | 7,110 | A-Award | A | 7,110 | 51.82 | 368,440.00 |
| 2023-06-07 | Sanders Corazon (Corsee) D. | director | 11,055 | A-Award | A | 3,860 | 0.00 | 0.00 |
| 2023-06-08 | Sanders Corazon (Corsee) D. | director | 9,570 | S-Sale | D | 1,485 | 51.65 | 76,700.00 |
| 2023-06-07 | Sanders Corazon (Corsee) D. | director | 7,110 | A-Award | A | 7,110 | 51.82 | 368,440.00 |
| 2023-06-07 | SULIMAN SHEHNAAZ | director | 14,855 | A-Award | A | 3,860 | 0.00 | 0.00 |
| 2023-06-07 | SULIMAN SHEHNAAZ | director | 7,110 | A-Award | A | 7,110 | 51.82 | 368,440.00 |
| 2023-06-07 | NARACHI MICHAEL | director | 21,605 | A-Award | A | 3,860 | 0.00 | 0.00 |
| 2023-06-07 | NARACHI MICHAEL | director | 7,110 | A-Award | A | 7,110 | 51.82 | 368,440.00 |
| 2023-06-07 | Dunsire Deborah | director | 19,730 | A-Award | A | 3,860 | 0.00 | 0.00 |
| 2023-06-07 | Dunsire Deborah | director | 7,110 | A-Award | A | 7,110 | 51.82 | 368,440.00 |
| 2023-06-07 | WELCH DANIEL G | director | 21,605 | A-Award | A | 3,860 | 0.00 | 0.00 |
| 2023-06-07 | WELCH DANIEL G | director | 7,110 | A-Award | A | 7,110 | 51.82 | 368,440.00 |
| 2023-05-18 | Pinion John Richard | officer: See Remarks | 74,744 | S-Sale | D | 2,012 | 50.00 | 100,600.00 |
| 2023-05-09 | Huizenga Theodore Alan | officer: SVP, Chief Accounting Officer | 30,747 | M-Exempt | A | 3,000 | 21.00 | 63,000.00 |
| 2023-05-09 | Huizenga Theodore Alan | officer: SVP, Chief Accounting Officer | 5,000 | M-Exempt | D | 3,000 | 21.00 | 63,000.00 |
| 2023-05-04 | Parschauer Karah Herdman | officer: EVP and Chief Legal Officer | 51,982 | S-Sale | D | 4,378 | 45.00 | 197,010.00 |
| 2023-05-01 | Crombez Eric | officer: EVP and Chief Medical Officer | 30,512 | A-Award | A | 4,658 | 0.00 | 0.00 |
| 2023-05-01 | Crombez Eric | officer: EVP and Chief Medical Officer | 8,362 | A-Award | A | 8,362 | 44.03 | 368,179.00 |
| 2023-05-01 | Crombez Eric | officer: EVP and Chief Medical Officer | 25,854 | D | 0 | 0.00 | 0.00 | |
| 2023-05-01 | Crombez Eric | officer: EVP and Chief Medical Officer | 0 | D | 7,500 | 48.11 | 360,825.00 | |
| 2023-05-01 | Crombez Eric | officer: EVP and Chief Medical Officer | 0 | D | 8,000 | 67.55 | 540,400.00 | |
| 2023-05-01 | Crombez Eric | officer: EVP and Chief Medical Officer | 0 | D | 13,000 | 56.08 | 729,040.00 | |
| 2023-05-01 | Crombez Eric | officer: EVP and Chief Medical Officer | 0 | D | 4,310 | 142.47 | 614,046.00 | |
| 2023-05-01 | Crombez Eric | officer: EVP and Chief Medical Officer | 0 | D | 6,335 | 67.37 | 426,789.00 | |
| 2023-05-01 | Crombez Eric | officer: EVP and Chief Medical Officer | 0 | D | 9,845 | 45.65 | 449,424.00 | |
| 2023-04-16 | Huizenga Theodore Alan | officer: SVP, Chief Accounting Officer | 27,701 | F-InKind | D | 14 | 38.20 | 534.80 |
| 2023-04-16 | Huizenga Theodore Alan | officer: SVP, Chief Accounting Officer | 27,520 | D-Return | D | 181 | 38.20 | 6,914.00 |
| 2023-03-01 | Bedrosian Camille L | officer: EVP and Chief Medical Officer | 50,601 | A-Award | A | 2,663 | 0.00 | 0.00 |
| 2023-03-01 | Bedrosian Camille L | officer: EVP and Chief Medical Officer | 46,720 | S-Sale | D | 3,881 | 45.25 | 175,615.00 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Inc. doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Inc. or anyone involved with Discounting Cash Flows Inc. will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
